Clinical Trial Update: A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the immune response and safety of a second dose of an investigational varicella (chickenpox) vaccine in healthy children, given 3 mon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Investigational varicella vaccine (varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chickenpox | Phase 3 | Status: RECRUITING